{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:20:56Z","timestamp":1792264856840,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010950","name":"Department of Science and Technology of Henan Province","doi-asserted-by":"publisher","award":["241111313500"],"award-info":[{"award-number":["241111313500"]}],"id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.psyneuen.2025.107551","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:51:45Z","timestamp":1752587505000},"page":"107551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Longitudinal association between plasma epidermal growth factor and the progression of anxiety and depressive symptoms in Parkinson's disease"],"prefix":"10.1016","volume":"180","author":[{"given":"Xue-Feng","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2025.107551_bib1","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1007\/s11064-022-03707-9","article-title":"Effect of epigallocatechin-3-gallate on stress-induced depression in a mouse model: role of interleukin-1\u03b2 and brain-derived neurotrophic factor","volume":"47","author":"Abdelmeguid","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psyneuen.2025.107551_bib2","doi-asserted-by":"crossref","DOI":"10.25270\/wmp.22094","article-title":"The effect of hyperbaric oxygen therapy on psychological state and wound healing: a case report","volume":"70","author":"Antunes","year":"2024","journal-title":"Wound Manag. Prev."},{"key":"10.1016\/j.psyneuen.2025.107551_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jad.2020.03.055","article-title":"Serum epidermal growth factor, clinical illness course, and limbic brain volumes in early-stage bipolar disorder","volume":"270","author":"Bond","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2025.107551_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis","volume":"31","author":"Broen","year":"2016","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.psyneuen.2025.107551_bib5","first-page":"1609","article-title":"Changes of wound area and inflammatory factors in diabetic foot patients after comprehensive nursing of traditional Chinese medicine","volume":"27","author":"Chen","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.psyneuen.2025.107551_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41586-025-08880-9","article-title":"Psychedelic control of neuroimmune interactions governing fear","volume":"641","author":"Chung","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2025.107551_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2011.01.021","article-title":"Factors associated with depression in Parkinson's disease","volume":"132","author":"Dissanayaka","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2025.107551_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.mp.4001138","article-title":"Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development","volume":"8","author":"Futamura","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2025.107551_bib9","article-title":"Correlation between plasma epidermal growth factor and follow-up cognitive decline in Parkinson's disease","author":"Gu","year":"2025","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.psyneuen.2025.107551_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14867","article-title":"Gray matter volume alterations in de novo Parkinson's disease: a mediational role in the interplay between sleep quality and anxiety","volume":"30","author":"He","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.psyneuen.2025.107551_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1414855","article-title":"Early identification of Parkinson's disease with anxiety based on combined clinical and MRI features","volume":"16","author":"Jia","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.psyneuen.2025.107551_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135273","article-title":"Association between epidermal growth factor receptor gene polymorphisms and susceptibility to Parkinson's disease","volume":"736","author":"Jin","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"Pt 4","key":"10.1016\/j.psyneuen.2025.107551_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.2044-8260.1983.tb00610.x","article-title":"Some norms and reliability data for the state--trait anxiety inventory and the zung self-rating depression scale","volume":"22","author":"Knight","year":"1983","journal-title":"Br. J. Clin. Psychol."},{"key":"10.1016\/j.psyneuen.2025.107551_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41531-023-00547-4","article-title":"Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies","volume":"9","author":"Lai","year":"2023","journal-title":"NPJ Park. 'S. Dis."},{"key":"10.1016\/j.psyneuen.2025.107551_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081776","article-title":"CB2 Agonist GW842166x protected against 6-OHDA-induced anxiogenic- and depressive-related behaviors in mice","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.psyneuen.2025.107551_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148893","article-title":"Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: modulation of dopamine D3 receptor","volume":"1834","author":"Mansour","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2025.107551_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00415-012-6648-6","article-title":"Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients","volume":"260","author":"Pellecchia","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.psyneuen.2025.107551_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s40266-022-00942-1","article-title":"Depression in patients with Parkinson's disease: current understanding of its neurobiology and implications for treatment","volume":"39","author":"Prange","year":"2022","journal-title":"Drugs Aging"},{"key":"10.1016\/j.psyneuen.2025.107551_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79166-9","article-title":"Increased serum EGF but not SDF-1 levels are associated with the pathophysiology and development of generalized anxiety disorder","volume":"14","author":"Roknuzzaman","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psyneuen.2025.107551_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1353759","article-title":"Longitudinal faster anxiety progression of GBA variant carriers in the early Parkinson's disease cohort","volume":"18","author":"Sang","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psyneuen.2025.107551_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mdc3.14145","article-title":"Association of baseline depression and anxiety with longitudinal health outcomes in Parkinson's disease","volume":"11","author":"Shi","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.psyneuen.2025.107551_bib22","first-page":"881","article-title":"Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson's disease patients","volume":"44","author":"Shi","year":"2023","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.psyneuen.2025.107551_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10184064","article-title":"Elevated epidermal growth factor (EGF) as candidate biomarker of mood disorders-longitudinal study in adolescent and young adult patients","volume":"10","author":"Skibinska","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.psyneuen.2025.107551_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111981","article-title":"Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety","volume":"371","author":"Vieira","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2025.107551_bib25","article-title":"Advances in the study of depression and anxiety in Parkinson's disease: a review","volume":"104","author":"Wang","year":"2025","journal-title":"Medicine"},{"key":"10.1016\/j.psyneuen.2025.107551_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.JGP.0000192488.66049.4b","article-title":"Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease","volume":"14","author":"Weintraub","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry"},{"key":"10.1016\/j.psyneuen.2025.107551_bib27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/gps.1785","article-title":"Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item geriatric depression scale (GDS-15)","volume":"22","author":"Weintraub","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psyneuen.2025.107551_bib28","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41386-020-0601-7","article-title":"ErbB4 knockdown in serotonergic neurons in the dorsal raphe induces anxiety-like behaviors","volume":"45","author":"Zhang","year":"2020","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453025002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453025002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:50:42Z","timestamp":1777557042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453025002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0306453025002744"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2025.107551","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal association between plasma epidermal growth factor and the progression of anxiety and depressive symptoms in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2025.107551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107551"}}